Crossmark

Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib

Crossref DOI link: https://doi.org/10.1007/s00277-018-3381-y

Published Online: 2018-05-26

Published Print: 2019-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wanner, David https://orcid.org/0000-0002-2485-6909
Bohn, Jan-Paul

Rudzki, Jakob

Stockhammer, Günther

Steurer, Michael
License Information

Text and Data Mining valid from 2018-05-26
More Information

Article History

Received: 23 April 2018

Accepted: 21 May 2018

First Online: 26 May 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.